U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07453862) titled 'Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety' on Feb. 02.
Brief Summary: The goal of this [study type: clinical trial] is to [primary purpose: evaluate the efficacy and safety of a novel calcium channel modulator in treating Restless Legs Syndrome (RLS) and its variant subtypes] in [describe participant population/primary condition: adult patients aged 18-75 years with confirmed RLS or its variant subtypes, who meet the study's eligibility criteria]. The main question[s] it aims to answer [is/are]:
* Does the novel calcium channel modulator improve RLS-related symptoms (assessed by the International Restl...